期刊文献+

高敏C反应蛋白在预测细菌性慢性阻塞性肺病急性加重中应用价值 被引量:4

Application value of high sensitive C reactive protein in predicting bacterial acute exacerbation of chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨血清高敏C反应蛋白(hs CRP)预测细菌性慢性阻塞性肺病急性加重(AECOPD)的价值。方法采用胶体金法测定86例老年AECOPD患者血清hs CRP水平,并对其进行痰细菌培养。绘制受试者操作特征(ROC)曲线,并计算曲线下面积。统计分析hs CRP与痰菌之间的关系。结果细菌性AECOPD患者(60例)血清hs CRP水平显著高于非细菌性AECOPD患者(26例)(t=6.898,P=0.000)。区分细菌性AECOPD和非细菌性AECOPD的hs CRP的理想阈值为29.85 mg/L(敏感性80.26%,特异性81.52%,曲线下面积0.863)。结论老年AECOPD患者血清hs CRP水平升高>29.85 mg/L提示为细菌感染导致的急性加重,并且可能是一个能指导抗生素治疗该疾病的潜在生物标志物。 Objective To explore the value of highly-sensitive C reactive protein (hsCRP) in predicting bacterial acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods Serum hsCRP levels of 86 aged patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) were assayed by colloidal gold method,and the bacteria in their sputum samples were cultured.Receiver operating characteristic (ROC) curve and the respective areas under the curve (AUC) were calculated.The correlation between hsCRP and bacterial colonies in the sputum samples was analyzed statistically.Results Serum hsCRP levels of 60 bacterial AECOPD patients were significantly higher than those of 26 nonbacterial AECOPD patients (t =6.898,P =0.000).The ideal cutoff point of hsCRP for distinguishing patients with bacterial AECOPD from those with nonbacterial AECOPD was 29.85 mg/L (sensitivity:80.26%,specificity:81.52%,AUC:0.863).Conclusions In old patients with AECOPD,an elevated serum hsCRP level > 29.85 mg/L indicates acute exacerbation induced by bacterial infection,which may be a potential biomarker in guiding antibiotic therapy of the disease.
作者 黄根牙
出处 《实用预防医学》 CAS 2014年第12期1517-1519,共3页 Practical Preventive Medicine
基金 镇江市社会发展基金项目(编号:SH2011029)
关键词 慢性阻塞性肺病 急性加重 C反应蛋白 细菌 Chronic obstructive pulmonary disease Acute exacerbation C-reactive protein Bacteria
  • 相关文献

参考文献16

  • 1Vestbo J, Hurd SS, Agustl AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease --CRDLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4) :347 - 365.
  • 2Bafadhel M, McKenna S, Terry S, e* al. Acute exacerbations o{ COPD: identification of biological clusters and their biomarkers[J]. Am J Re- spir Crit Care Med,2011,184(6) :662 - 671.
  • 3黄根牙,顾新元,唐利龙.C反应蛋白致动脉粥样硬化的作用[J].国际心血管病杂志,2008,35(6):363-366. 被引量:5
  • 4刘翠兰.高敏C反应蛋白在不同类型冠心病中水平测定及其临床意义[J].实用预防医学,2013,20(5):617-618. 被引量:7
  • 5Tofan F, Rahimi- Rad MH, Rasmi Y, et al. High sensitive C- reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease [ J 1. Pneumologia, 2012,61 (3) : 160 - 162.
  • 6Brightling CE. Biomarkers that predict and guide therapy for exacerba- tions of chronic obstructive pulmonary disease [J~. Ann Am Thorac Soc, 2013,10 (Suppl) :$214 - 219.
  • 7Daniels JM, Schoorl M, Snijders D, et al. Procalcitonin vs C - reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of CDPD[ J ]. Chest, 2010,138 (5) ~ 1108 - 1115.
  • 8慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264. 被引量:3883
  • 9Hurst JR, Wilkinson TM, Perera WR, et al. Relationships among bacte- ria, upper airway, lower airway, and systemic inflammation in COPD [J]. Chest,2005,127(4) :1219 - 1226.
  • 10White AJ, Gompertz S, Bayley DL, et al. Resolution of bronchial in- flammation is related to bacterial eradication {ollowing treatment of ex- acerbations of chronic bronchitis[J]. Thorax, 2003,58 (8) : 680 - 685.

二级参考文献87

共引文献3904

同被引文献23

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部